Development
Cardio Diagnostics Holdings, Inc.
CDIO
$4.77
$0.2455.42%
NASDAQ
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 488.24% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 488.24% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 488.24% | -- | |||
| SG&A Expenses | -44.41% | 57.46% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -43.08% | 50.01% | |||
| Operating Income | 43.43% | -49.91% | |||
| Income Before Tax | 51.97% | -289.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 51.97% | -289.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 51.97% | -289.59% | |||
| EBIT | 43.43% | -49.91% | |||
| EBITDA | 44.90% | -50.05% | |||
| EPS Basic | 58.68% | -263.03% | |||
| Normalized Basic EPS | 51.90% | -230.33% | |||
| EPS Diluted | 58.68% | -263.03% | |||
| Normalized Diluted EPS | 51.90% | -230.33% | |||
| Average Basic Shares Outstanding | 16.22% | 7.28% | |||
| Average Diluted Shares Outstanding | 16.22% | 7.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||